Medical specialists from Spain tagged as investigators in clinical trials studying Achondroplasia
Total 4 results
-
Antonio Leiva Gea, M.D.Seen in:
- Málaga, Hospital Universitario Virgen de La Victoria
Trials:- NCT04035811 (Principal Investigator)
Conditions: -
Fernando Santos Simarro, M.D.Seen in:
- Madrid, Hospital Universitario la Paz
Trials:- NCT04035811 (Principal Investigator)
Conditions: -
Jorge Knörr, M.D.Seen in:
- Barcelona, Vithas Hospital San Jose
Trials:- NCT04035811 (Principal Investigator)
Conditions: -
Josep M de Bergua, MDSeen in:
- Álava, Vitoria-Gasteiz, Hospital Vithas San Jose
Trials:- NCT05145010 (Principal Investigator)
Conditions:
Clinical Trials on Achondroplasia
-
GeneScience Pharmaceuticals Co., Ltd.Tongji Hospital; Shengjing Hospital; Shandong Provincial Hospital; Children's Hospital... and other collaboratorsRecruiting
-
Johns Hopkins UniversityUniversity of Wisconsin, Madison; University of Texas; BioMarin Pharmaceutical; Alfred I. duPont Hospital for Children and other collaboratorsEnrolling by invitationAchondroplasia
-
PfizerTerminatedAchondroplasiaBelgium, United States, Japan, Australia, Portugal, Denmark, Italy, Spain
-
PfizerTerminatedAchondroplasiaUnited States, Australia, Belgium, Denmark, Italy, Portugal, Spain
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, Japan, United Kingdom
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaAustralia, United Kingdom
-
BioMarin PharmaceuticalCompletedAchondroplasiaUnited States, Australia, United Kingdom, Japan, Spain, Turkey
-
BioMarin PharmaceuticalPicnicHealthRecruitingAchondroplasiaUnited States
-
Ascendis Pharma Growth Disorders A/SActive, not recruitingAchondroplasiaUnited States, Denmark, Ireland, New Zealand, Australia, Canada, Spain
-
Ascendis Pharma A/SActive, not recruitingAchondroplasiaUnited States, Australia, Austria, Denmark, Germany, Ireland, New Zealand, Portugal